Visual inspection alone is insufficient to diagnose skin cancer

NewsGuard 100/100 Score

A large-scale systematic review of research into the accuracy of skin cancer diagnostics has found that visual inspection of suspicious lesions is insufficient to ensure an accurate diagnosis.

Skin lesion being examined - iMoved Studio

iMoved Studio | Shutterstock

The review, which has recently been published in The Cochrane Library, summarises a large body of research looking at the accuracy of tests in supporting decision making in skin cancer diagnosis.

The early and accurate detection of all types of skin cancer is essential to managing the disease and to improving survival rates in melanoma, especially given the rising prevalence of skin cancer worldwide, says study leader Jac Dinnes from the University of Birmingham.

The visual nature of skin cancer means that it can be detected and treated in many different ways and by a number of different types of specialists, therefore the aim of these reviews is to provide the world's best evidence for how this endemic type of cancer should be identified and treated.

Jac Dinnes, Study Leader

The study findings suggest that careful consideration should be given to the technologies used, in order to ensure skin cancers are not missed, says Dinnes.

Inappropriate referrals to specialists and inappropriate removal of benign lesions also need to be kept to a minimum.

Key points made in the review include that examination by the naked eye alone is not sufficient and may lead to melanomas being missed. It also states that smartphone applications used to check skin lesions are also likely to miss melanoma.

Dermoscopy, which uses a handheld device to zoom in on a mole, is better at diagnosing melanoma than visual inspection and may help GPs establish which patients need to be referred to a specialist.

Artificial intelligence techniques, such as computer-assisted diagnosis (CAD), can identify more melanomas than dermoscopy, but these techniques generate far more false positives than dermoscopy and could lead to significant increases in inappropriate surgery.

Although some useful conclusions have emerged, for example, on the role of dermoscopy, the greatest value of the research is to serve as a yardstick for designing future studies evaluating skin cancer diagnosis techniques on patients who are typically seen in GP and specialist settings."

Professor Hywel Williams, Cochrane Skin Group Founder

Sally Robertson

Written by

Sally Robertson

Sally first developed an interest in medical communications when she took on the role of Journal Development Editor for BioMed Central (BMC), after having graduated with a degree in biomedical science from Greenwich University.


Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Robertson, Sally. (2019, June 19). Visual inspection alone is insufficient to diagnose skin cancer. News-Medical. Retrieved on April 25, 2024 from

  • MLA

    Robertson, Sally. "Visual inspection alone is insufficient to diagnose skin cancer". News-Medical. 25 April 2024. <>.

  • Chicago

    Robertson, Sally. "Visual inspection alone is insufficient to diagnose skin cancer". News-Medical. (accessed April 25, 2024).

  • Harvard

    Robertson, Sally. 2019. Visual inspection alone is insufficient to diagnose skin cancer. News-Medical, viewed 25 April 2024,


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.